While in ER+ breast cancer the presence of GR has been reported to have a favourable prognosis, probably due to crosstalk between the two nuclear receptors [14], in ER− (and triple-negative) breast cancer, GCs supported cancer growth and metastasis leading to enhanced aggressiveness [14,15,16,17] (Figure 1). This evidence concerns the gene NR3C1 and cancer.